DMS Pharmaceutical Group Government Contracts
DMS Pharmaceutical Group Inc · UEI PX72BSBQTKJ3
DMS Pharmaceutical Group government contracts totaled $760M across 107,622 awards from FY2024 to FY2026. Obligations were down 32.7% in FY2026 vs FY2025, and the Department of Defense accounted for $760M (100% of the total); Drugs and Druggists' Sundries Merchant Wholesalers accounted for $694M (91% of the total).
Key figures
In FY2026, contract obligations were $201,201,878 across 30,705 awards with activity that year, a change of -32.7% from $299,158,971 in FY2025. From FY2024 to FY2026, obligations totaled $760,437,518 across 107,622 awards.
- Obligated in FY2026
- $201M
- Awards in FY2026
- 30,705
- Change vs FY2025
- -32.7%
- Total, FY2024 to FY2026
- $760M
Note: FY2026 ended on Sep 30, 2026. The Department of Defense publishes contract data with a 90-day delay, so FY2026 totals may still rise as late reports arrive.
DMS Pharmaceutical Group federal contracts by year
DMS Pharmaceutical Group federal contract obligations per fiscal year (October to September). The table below lists the same numbers.
| Fiscal year | Obligated | Awards | Change |
|---|---|---|---|
| FY2026 | $201,201,878 | 30,705 | -32.7% |
| FY2025 | $299,158,971 | 40,396 | +15% |
| FY2024 | $260,076,670 | 39,418 | n/a |
About DMS Pharmaceutical Group's federal contracts
DMS Pharmaceutical Group's federal contract obligations fell 23% from FY2024 ($260M) to FY2026 ($201M), peaking in FY2025. FY2026 closed recently, and Defense Department contracts are reported up to 90 days late, so its total may still rise.
Nearly all of DMS Pharmaceutical Group's government contracts come from one customer, the Department of Defense (100%).
Its main line of government work is drugs and druggists' sundries merchant wholesalers (NAICS 424210), 91% of its federal contract dollars.
The states with the most DMS Pharmaceutical Group contract work are Illinois, Pennsylvania and North Carolina; Illinois alone accounts for 98%.
Which agencies award DMS Pharmaceutical Group contracts
Federal agencies ranked by contract dollars obligated to DMS Pharmaceutical Group Inc. DMS Pharmaceutical Group DoD contracts account for 100% of its federal contract dollars.
| # | Agency | Obligated | Share |
|---|---|---|---|
| 1 | Department of Defense | $760,244,407 | 100.0% |
| 2 | Department of Veterans Affairs | $193,112 | <0.1% |
DMS Pharmaceutical Group contracts by industry (NAICS)
The industry codes on DMS Pharmaceutical Group's contracts with the government, ranked by dollars.
| # | Industry | Obligated | Share |
|---|---|---|---|
| 1 | Drugs and Druggists' Sundries Merchant WholesalersNAICS 424210 | $693,509,049 | 91.2% |
| 2 | Medicinal and Botanical ManufacturingNAICS 325411 | $59,387,154 | 7.8% |
| 3 | Pharmaceutical Preparation ManufacturingNAICS 325412 | $7,238,508 | 1.0% |
| 4 | Medical, Dental, and Hospital Equipment and Supplies Merchant WholesalersNAICS 423450 | $296,010 | <0.1% |
| 5 | Biological Product (except Diagnostic) ManufacturingNAICS 325414 | $5,835 | <0.1% |
| 6 | All Other Health and Personal Care RetailersNAICS 456199 | $1,514 | <0.1% |
Where DMS Pharmaceutical Group contract work is performed
States ranked by contract dollars, using the place of performance on each award.
| # | State | Obligated | Share |
|---|---|---|---|
| 1 | Illinois | $742,907,505 | 97.7% |
| 2 | Pennsylvania | $17,510,078 | 2.3% |
| 3 | North Carolina | $18,016 | <0.1% |
| 4 | New York | $1,920 | <0.1% |
Recent DMS Pharmaceutical Group contract awards
The latest DMS Pharmaceutical Group contract awards, newest first. Each award ID links to its record on USAspending.gov.
| Start date | Agency and description | Amount | Record |
|---|---|---|---|
| Jul 30, 2026 | Department of Defense8512274429!HYDROCORTISONE CREA | $449 | SPE2DP26F8478 |
| Jul 30, 2026 | Department of Defense8512273195!BISMUTH SUBSALICYLATE TABLETS | $22 | SPE2DP26F8455 |
| Jul 30, 2026 | Department of Defense8512273147!ASPIRIN TABLETS,USP | $11 | SPE2DP26F8448 |
| Jul 29, 2026 | Department of Defense8512271544!HYDROCORTISONE CREA | $242 | SPE2DP26F8405 |
| Jul 29, 2026 | Department of Defense8512270175!HYDROCORTISONE CREA | $288 | SPE2DP26F8391 |
| Jul 29, 2026 | Department of Defense8512270148!BACITRACIN OINTMENT | $185 | SPE2DP26F8392 |
| Jul 28, 2026 | Department of Defense8512267370!HYDROCORTISONE CREA | $115 | SPE2DP26F8355 |
| Jul 27, 2026 | Department of Defense8512264074!NALOXONE HYDROCHLOR | $1,621 | SPE2DP26F8307 |
| Jul 24, 2026 | Department of Defense8512261438!HYDROCHLOROTHIAZIDE TABLETS | $40 | SPE2DP26F8054 |
| Jul 24, 2026 | Department of Defense8512261652!INDOMETHACIN CAPSULES | $47 | SPE2DP26F8121 |
| Jul 24, 2026 | Department of Defense8512261660!TRIAMCINOLONE ACETONIDE INJEC | $34 | SPE2DP26F8104 |
| Jul 24, 2026 | Department of Defense8512261545!TRIAMCINOLONE ACETONIDE INJEC | $34 | SPE2DP26F8072 |
| Jul 24, 2026 | Department of Defense8512260978!FERROUS SULFATE TABLETS | $1 | SPE2DP26F8021 |
| Jul 24, 2026 | Department of Defense8512261082!INDOMETHACIN CAPSULES | $12 | SPE2D226F3087 |
| Jul 24, 2026 | Department of Defense8512261120!LISINOPRIL TABLETS | $3 | SPE2D226F3085 |
| Jul 24, 2026 | Department of Defense8512260931!ONDANSETRON HYDROCH | $21 | SPE2D226F3080 |
| Jul 23, 2026 | Department of Defense4572470119!PHARMACEUTICAL PV DIV - FSB | $4,389 | SPE2DU26FEPDD |
| Jul 23, 2026 | Department of Defense4572467320!PHARMACEUTICAL PV DIV - FSB | $12,721 | SPE2DU26FEPDC |
| Jul 23, 2026 | Department of Defense4572480918!PHARMACEUTICAL PV DIV - FSB | $87,456 | SPE2DU26FENBS |
| Jul 23, 2026 | Department of Defense4572509612!PHARMACEUTICAL PV DIV - FSB | $21,425 | SPE2DU26FELXT |
| Jul 23, 2026 | Department of Defense4572477051!PHARM PRIME VENDOR FLEET | $57 | SPE2DU26F1Z16 |
| Jul 23, 2026 | Department of Defense4572603399!PHARM PRIME VENDOR FLEET | $81 | SPE2DU26F1Z12 |
| Jul 23, 2026 | Department of Defense4572957350!PHARM PRIME VENDOR FLEET | $192 | SPE2DU26F1Y86 |
| Jul 23, 2026 | Department of Defense4572512410!PHARM PRIME VENDOR FLEET | $2,890 | SPE2DU26F1Y85 |
| Jul 23, 2026 | Department of Defense4572681081!PHARM PRIME VENDOR FLEET | $6,521 | SPE2DU26F1Y82 |
Subcontracting opportunities with DMS Pharmaceutical Group
Large prime contractors such as DMS Pharmaceutical Group buy goods and services from smaller firms for parts of their government contracts. If you work in the same industries or states, DMS Pharmaceutical Group is a possible teaming partner: read its recent contract awards above, then contact its small business or supplier diversity office with your capability statement.
Explore government contracts related to DMS Pharmaceutical Group
- Government drugs and druggists' sundries merchant wholesalers contracts
- Government medicinal and botanical manufacturing contracts
- Government pharmaceutical preparation manufacturing contracts
- Government medical supplies contracts
- Government biological product (except diagnostic) manufacturing contracts
- Department of Defense contracts
- Department of Veterans Affairs contracts
- Government contracts in Illinois
- Government contracts in Pennsylvania
- Government contracts in North Carolina
- Government contracts in New York
Frequently asked questions
- How much does DMS Pharmaceutical Group make from government contracts?
- DMS Pharmaceutical Group Inc received $760M in federal contract obligations from FY2024 to FY2026, across 107,622 contract awards. In FY2026 alone it received $201M. Figures are federal contract obligations reported on USAspending.gov.
- Which agency spends the most with DMS Pharmaceutical Group?
- The Department of Defense obligated $760M to DMS Pharmaceutical Group from FY2024 to FY2026, 100% of its federal contract dollars.
- What does DMS Pharmaceutical Group do for the government?
- By contract dollars, DMS Pharmaceutical Group's largest federal contract industries are drugs and druggists' sundries merchant wholesalers (NAICS 424210), medicinal and botanical manufacturing (NAICS 325411) and pharmaceutical preparation manufacturing (NAICS 325412).
- Where does DMS Pharmaceutical Group perform its government contracts?
- By place of performance, the most DMS Pharmaceutical Group contract dollars went to work in Illinois ($743M), Pennsylvania ($17.5M) and North Carolina ($18K).
- Are DMS Pharmaceutical Group's government contracts growing?
- DMS Pharmaceutical Group's federal contract obligations fell 23% from FY2024 ($260M) to FY2026 ($201M), peaking in FY2025. FY2026 closed recently, and Defense Department contracts are reported up to 90 days late, so its total may still rise.
- How can a small business subcontract with DMS Pharmaceutical Group?
- Look at the agencies and industries DMS Pharmaceutical Group works in on this page, then contact its small business or supplier diversity office with a capability statement. Large prime contractors often have to meet small business subcontracting goals, and you will need a free SAM.gov registration.